RxDoctor Payments Data

Herbert Silverstein, MD

Otology & Neurotology · Sarasota, FLNPI 1295745305

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $18,162 of the $18,360 with a category attached, or 98.9%. Medtronic accounts for 98.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $5,292 and has fallen 83.3% since, to $886 in 2024.

$18,360in general payments, 2019–2025

Across 25 payments — averaging $734.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$18K
  • Impulse Dynamics (USA) Inc.$143
  • Johnson & Johnson$30
  • Acclarent, Inc$26
$3,479,580in research payments, 2019–2025

Across 30 payments — averaging $115,986 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otonomy, Inc.$3.5M

What the payments were for

  • Royalty or licence$18,16299%
  • Food & beverage$1981%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)21$18,162
Impulse Dynamics (USA) Inc.1$143
Johnson & Johnson1$30
Acclarent, Inc2$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,360 in reported general payments places this provider in the 85th percentile of 25 otology & neurotology providers in Florida.

See all otology & neurotology providers in Florida

Medicare billing

Part B allowed, 2024
$30,595
Medicare patients
151
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otology & neurotology in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →